These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31013189)

  • 21. Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
    Sin EI; Chia CS; Tan GHC; Soo KC; Teo MC
    Int J Hyperthermia; 2017 Sep; 33(6):690-695. PubMed ID: 28540777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-admissions for delayed complications after cytoreductive surgery and HIPEC.
    Spiliotis J; Argiriou EO; Vafias E; Manou V; Vaos N; Datsis A; Efstathiou E
    Acta Chir Belg; 2016 Apr; 116(2):96-100. PubMed ID: 27385296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
    World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of MaxZero™ needle-free connector on the incidence of central venous catheter-related infections in surgical intensive care unit.
    Clavier T; Ferguen M; Gouin P; Gillibert A; Dusenne M; Merle V; Veber B
    Aust Crit Care; 2019 Mar; 32(2):107-111. PubMed ID: 29653801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Rottenstreich A; Kalish Y; Kleinstern G; Yaacov AB; Dux J; Nissan A
    J Surg Oncol; 2017 Dec; 116(7):914-920. PubMed ID: 28650573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digestive fistulas after cytoreductive surgery & HIPEC in peritoneal carcinomatosis.
    Halkia E; Efstathiou E; Rogdakis A; Christakis C; Spiliotis J
    J BUON; 2015 May; 20 Suppl 1():S60-3. PubMed ID: 26051334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of catheter-related blood stream infection: back to basics?
    Cherry-Bukowiec JR; Denchev K; Dickinson S; Chenoweth CE; Zalewski C; Meldrum C; Sihler KC; Brunsvold ME; Papadimos TJ; Park PK; Napolitano LM
    Surg Infect (Larchmt); 2011 Feb; 12(1):27-32. PubMed ID: 21171811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrotoxicity and long-term survival investigations for patients with peritoneal carcinomatosis using hyperthermic intraperitoneal chemotherapy with cisplatin: A retrospective cohort study.
    Ye J; Ren Y; Wei Z; Peng J; Chen C; Song W; Tan M; He Y; Yuan Y
    Surg Oncol; 2018 Sep; 27(3):456-461. PubMed ID: 30217302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
    Chouliaras K; Levine EA; Fino N; Shen P; Votanopoulos KI
    Ann Surg Oncol; 2017 Apr; 24(4):890-897. PubMed ID: 27995450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rethinking Routine Intensive Care After Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy: The Fiscal Argument.
    Schwartz PB; Stahl CC; Vidri RJ; Leverson GE; Puckett Y; Zafar SN; Varley P; Ronnekleiv-Kelly SM; Al-Niaimi A; Weber SM; Abbott DE
    Ann Surg Oncol; 2022 Oct; 29(11):6606-6614. PubMed ID: 35672624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly Patients: Complete Cytoreduction Is Feasible and Crucial for Improved Survival Despite High Carcinomatosis Index.
    Naffouje SA; Salti GI
    Anticancer Res; 2018 Jan; 38(1):441-448. PubMed ID: 29277807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
    Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
    J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.
    Downs-Canner S; Ding Y; Magge DR; Jones H; Ramalingam L; Zureikat A; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2015 May; 22(5):1651-7. PubMed ID: 25348781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Solomon D; DeNicola NL; Feferman Y; Bekhor E; Reppucci ML; Feingold D; Aycart SN; Magge DR; Golas BJ; Labow DM; Sarpel U
    Ann Surg Oncol; 2019 Mar; 26(3):845-851. PubMed ID: 30643994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Cytoreductive Surgery and HIPEC on Intraoperative Gastrointestinal Wall Thickness and Patient Outcomes.
    Chen MZ; Chan DL; Alshahrani MS; Altoukhi K; Alzahrani N; Morris DL
    Anticancer Res; 2020 May; 40(5):2865-2869. PubMed ID: 32366436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and risks for infection following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
    Smibert OC; Slavin MA; Teh B; Heriot AG; Penno J; Ismail H; Thursky KA; Worth LJ
    Support Care Cancer; 2020 Jun; 28(6):2745-2752. PubMed ID: 31712951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothermia Is Associated with Surgical Site Infection in Cytoreductive Surgery with Hyperthermic Intra-Peritoneal Chemotherapy.
    Eng OS; Raoof M; O'Leary MP; Lew MW; Wakabayashi MT; Paz IB; Melstrom LG; Lee B
    Surg Infect (Larchmt); 2018; 19(6):618-621. PubMed ID: 30044187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.